Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 338.54 USD -1.14%
Market Cap: 7.5B USD

EV/FCFF
Enterprise Value to FCFF

-14.1
Current
-11.2
Median
3.2
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-14.1
=
Enterprise Value
6.5B USD
/
FCFF
-462m USD
 
US
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Average EV/FCFF: 24
Negative Multiple: -14.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -227 401.1
US
Abbvie Inc
NYSE:ABBV
24.2
US
Amgen Inc
NASDAQ:AMGN
20.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -126.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -493.2
AU
CSL Ltd
ASX:CSL
45.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.3

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A